Rhenman & Partners Asset Management AB Has $21.59 Million Holdings in UnitedHealth Group Incorporated $UNH

Rhenman & Partners Asset Management AB boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 105.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 62,530 shares of the healthcare conglomerate’s stock after purchasing an additional 32,100 shares during the period. UnitedHealth Group comprises 2.4% of Rhenman & Partners Asset Management AB’s portfolio, making the stock its 7th biggest holding. Rhenman & Partners Asset Management AB’s holdings in UnitedHealth Group were worth $21,592,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Guerra Advisors Inc bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $1,059,000. Berkshire Hathaway Inc bought a new position in shares of UnitedHealth Group in the second quarter worth about $1,572,193,000. Carnegie Investment Counsel increased its holdings in UnitedHealth Group by 2.2% in the 3rd quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock worth $36,471,000 after acquiring an additional 2,316 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 48.9% in the second quarter. EverSource Wealth Advisors LLC now owns 5,790 shares of the healthcare conglomerate’s stock worth $1,806,000 after purchasing an additional 1,901 shares during the period. Finally, Phoenix Financial Ltd. raised its position in shares of UnitedHealth Group by 111.5% during the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock valued at $14,282,000 after purchasing an additional 22,137 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. JPMorgan Chase & Co. cut their price target on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research note on Monday, February 2nd. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Mizuho reduced their price objective on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. Jefferies Financial Group cut their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Finally, UBS Group reduced their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Price Performance

UNH opened at $286.86 on Friday. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The business has a fifty day moving average of $308.28 and a 200 day moving average of $325.83. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The stock has a market cap of $260.38 billion, a P/E ratio of 21.75, a PEG ratio of 1.32 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period in the previous year, the firm earned $6.81 earnings per share. The business’s revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be issued a $2.21 dividend. The ex-dividend date is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group’s payout ratio is presently 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.